unknown
Stage
About
Deverra Therapeutics is a clinical-stage biotechnology company developing allogeneic, off-the-shelf universal donor cellular immunotherapies using umbilical cord blood–derived cells for treatment of cancer and infectious diseases.
Explore Deverra Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.